# Clinical Evaluation of Removing Blood Stasis Therapy in Treating Acute Cerebral Hemorrhage Safety and Efficacy

> **NCT03354026** · PHASE4 · UNKNOWN · sponsor: **Guangzhou University of Traditional Chinese Medicine** · enrollment: 306 (estimated)

## Conditions studied

- Intracerebral Hemorrhage, Hypertensive
- Traditional Chinese Medicine

## Interventions

- **DRUG:** AICH-PXZY
- **DRUG:** AICH-without PXZY
- **DRUG:** AICH-placebo

## Key facts

- **NCT ID:** NCT03354026
- **Lead sponsor:** Guangzhou University of Traditional Chinese Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-11
- **Primary completion:** 2022-12
- **Final completion:** 2022-12
- **Target enrollment:** 306 (ESTIMATED)
- **Last updated:** 2017-11-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03354026

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03354026, "Clinical Evaluation of Removing Blood Stasis Therapy in Treating Acute Cerebral Hemorrhage Safety and Efficacy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03354026. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*